Elsevier

Blood Reviews

Volume 7, Issue 1, March 1993, Pages 43-51
Blood Reviews

Hepatic veno-occlusive disease after bone marrow transplant

https://doi.org/10.1016/0268-960X(93)90023-WGet rights and content

Abstract

Hepatic veno-occlusive disease (VOD) is a non-thrombotic obliteration of the lumina of small intrahepatic veins. VOD has been reported after exposure to a wide variety of pathogens. It has been suggested that the chemoradiotherapy used as the conditioning regimen for bone marrow transplant (BMT) is now the main cause of this disease. However, the pathogenesis of VOD after BMT is probably multifactorial. Endothelial injury of sinusoids and small hepatic veins is considered to be the initial event in genesis of VOD. This injury is followed by deposition of fibrin-related aggregates in the subendothelial zone. These aggregates, and the intramural entrapment of fluid and cellular debris, occlude progressively the hepatic venous outflow and generate a postsinusoidal intrahepatic hypertension. Clinically, VOD is characterized by jaundice, weight gain, ascites, painful hepatomegaly and platelet refractoriness developing early post transplant, although other postransplant liver disturbances can produce a similar syndrome. VOD diagnosis is usually established by applying the clinical criteria proposed by the Seattle and Baltimore groups. When clinical diagnosis of VOD is uncertain, a transjugular liver study including a transvenous biopsy and measurement of the gradient between wedged and free hepatic venous pressure, is recommended in order to establish an accurate diagnosis. According to the literature data, the incidence of VOD ranges from 0 to 70% and its mortality from 20 to 50%. This very wide range is attributable to the different incidence of risk factors in the different series and to the differences in applying the diagnostic criteria. Pretransplant liver disease, conditioning regiment intensity and composition, and use of other hepatotoxic drugs are proven risk factors for VOD. Other factors, such as the type of transplant or patient age, have been suspected but not definitively confirmed. There are no specific measures for VOD prophylaxis and treatment, but some prospective randomized studies are in progress in order to evaluate promising approaches.

References (102)

  • DW Beelen et al.

    Acute toxicity ans first clinical results of intensive postinduction therapy using a modified busulfan and cyclophosphamide regimen with autologous bone marrow rescue in first remission of acute myeloid leukemia

    Blood

    (1989)
  • JH Essell et al.

    Marked increase in veno-occlusive disease of the liver associated with methotrexate use for graft-versus-host disease prophylaxis in patients receiving Busulfan/Cyclophosphamide

    Blood

    (1992)
  • JM Cosset et al.

    Single dose versus hyperfractionated total body irradiation before allogeneic bone marrow transplantation: a non-randomized comparative study of 54 patients at the Institut Gustave-Roussy

    Radiother Oncol

    (1989)
  • TH Kim et al.

    Comparison of two total body irradiation regimens in allogeneic bone marrow transplantation for acute non-lymphoblastic leukemia in first remission

    Int J Radiat Oncol Biol Phys

    (1990)
  • JH Essell et al.

    Pilot trial of prophylactic ursodiol to decrease the incidence of veno-occlusive disease of the liver in allogeneic bone marrow transplant patients

    Bone Marrow Transplant

    (1992)
  • A Ibrahim et al.

    Hepatic veno-occlusive disease following bone marrow transplantation treated by prostaglandin E1

    Bone Marrow Transplant

    (1991)
  • G Rosti et al.

    Alteplase for hepatic veno-occlusive disease after bone-marrow transplantation

    Lancet

    (1992)
  • G Selzer et al.

    Senecio poisoning exhibiting as Chiari's syndrome

    Am J Pathol

    (1951)
  • D Valla et al.

    Disorders of the hepatic veins and venules

  • P Jacobs et al.

    Fatal venoocclusive disease of the liver after chemotherapy, whole-body irradiation and bone marrow transplantation for refractory acute leukemia

    S Afr Med J

    (1979)
  • HM Shulman et al.

    Hepatic veno-occlusive disease—liver toxicity syndrome after bone marrow transplantation

    Bone Marrow Transplant

    (1992)
  • GB McDonald et al.

    Liver disease after human marrow transplantation

    Semin Liv Dis

    (1987)
  • HM Shulman et al.

    Liver disease after bone marrow transplantation

  • E Carreras et al.

    Transjugular liver biopsy in BMT

    Bone Marrow Transplant

    (1993)
  • LF Fajardo et al.

    Pathogenesis of veno-occlusive liver disease after radiation

    Arch Pathol Lab Med

    (1980)
  • HM Shulman et al.

    Hepatic venoocclusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules

    Am J Pathol

    (1987)
  • RJ Jones et al.

    Venoocclusive disease of the liver following bone marrow transplantation

    Transplantation

    (1987)
  • H Weitz et al.

    Veno-occlusive disease of the liver in patients receiving immunosuppressive therapy

    Virchows Arch Pathol Anat

    (1982)
  • DC Snover et al.

    Nodular regenerative hyperplasia of the liver following bone marrow transplantation

    Hepatology

    (1989)
  • HM Shulman et al.

    Liver toxicity after bone marrow transplantation: correlation between coded autopsy histology and clinical features

    Lab Invest

    (1992)
  • D Lebrec et al.

    Noncirrhotic intrahepatic portal hypertension

    Semin Liver Dis

    (1986)
  • LK Johnson et al.

    Differential radiation: response of cultured endothelial cells and smooth myocytes

    Ann Quant Cytol

    (1982)
  • JR Allen et al.

    Hepatic veins of monkeys with veno-occlusive disease. Sequential ultrastructural changes

    Arch Pathol

    (1969)
  • SEH Brooks et al.

    Acute venoocclusive disease of the liver: Fine structure in Jamaican children

    Arch Pathol

    (1970)
  • HI Bicher et al.

    Effect of ionizing radiation on liver microcirculation and oxigenation

    Adv Exp Med Biol

    (1976)
  • PL Harper et al.

    Changes in the natural anticoagulants following bone marrow transplantation

    Bone Marrow Transplant

    (1990)
  • JC Reverter et al.

    Hemostatic alterations in bone marrow transplantation and their relationship with liver venocclusive disease

    Schweiz med Wschr

    (1991)
  • B Gordon et al.

    High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma

    Bone Marrow Transplant

    (1991)
  • P Collins et al.

    Haemostatic changes in uncomplicated bone marrow transplantation

    Bone Marrow Transplant

    (1991)
  • EM Faioni et al.

    Procoagulant inbalance due to low levels of protein C in patients with venocclusive disease (VOD) of the liver after bone marrow transplantation

    Blood

    (1991)
  • KA Bauer et al.

    Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans

    Blood

    (1990)
  • PP Nawroth et al.

    Interleukin-1 induces modulation of endothelial cells procoagulant while suppressing cell surface anticoagulant activity

  • JW Baars et al.

    Interleukin-2 induces activation of coagulation and fibrinolysis: resemblance to changes seen during experimental endotoxaemia

    Br J Haematol

    (1992)
  • LRI Baker et al.

    Enhanced in vitro hemostasis and reduced thrombolysis in cyclosporine-treated renal transplant recipients

    Transplantation

    (1990)
  • GB McDonald et al.

    Liver toxicity following cytoreductive therapy for marrow transplantation: Risk factors, incidence and outcome

    Hepatology

    (1991)
  • GB McDonald et al.

    Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors

    Hepatology

    (1984)
  • PD Berk et al.

    Veno-occlusive disease of the liver after allogeneic bone marrow transplantation. Possible association with graft versus host disease

    Ann Intern Med

    (1979)
  • RJ Soiffer et al.

    Hepatic dysfunction following T-cell-depleted allogeneic bone marrow transplantation

    Transplantation

    (1991)
  • D Pessayre et al.

    Drug-induced liver injury

  • BA Teicher et al.

    Glutathione monoethyl ester can selectively protect liver from high dose BCNU or cyclophosphamide

    Cancer

    (1988)

    • Cited by (57)

    • Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study

      2022, Transplantation and Cellular Therapy
      Citation Excerpt :

      SOS/VOD prophylaxis with defibrotide (Prociclide; Crinos, Como, Italy) 200-400 mg (10-25 mg/kg/d in children weighing less than 30 kg) i.v. in normal saline solution over 2 hours 4 times daily was initiated the day before starting the conditioning regimen and continued until day 20 after transplantation. Patients at higher risk of developing SOS/VOD, such as those with pretransplantation liver disturbance, pretransplantation abdominal irradiation, previous stem cell transplantation [1,31,32] received the higher dosage (400 mg 4 times daily) as compared to standard doses (200 mg 4 times daily) in standard-risk adult patients. In addition, low-dose heparin (5000 IU i.v. continuous/24h if weight <70 kg or 10,000 IU if weight >70 kg) was given routinely [33].

    • New Ultrasound Techniques Challenge the Diagnosis of Sinusoidal Obstruction Syndrome

      2018, Ultrasound in Medicine and Biology
      Citation Excerpt :

      In general, invasive diagnostic measures are not required or justified for the diagnosis of SOS/VOD (Carreras et al. 1993a, 1993b; Mohty et al. 2016), and liver biopsy is seldom performed for the diagnosis of SOS/VOD in the first day after transplantation. On a few occasions, histologic examination of hepatic tissue may be important mainly for differential diagnosis, to avoid underestimation of co-morbidities and false-positive diagnosis (Carreras et al. 1993a, 1993b; Shulman et al. 1995). If a liver biopsy is indicated early post-transplantation, transjugular liver biopsy is the recommended approach rather than percutaneous liver biopsy because with the former procedure, it is possible to perform multiple passes to obtain quality samples, minimizing the risk of complications related to the procedure in general (Kalambokis et al. 2007).

    • Hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation in adult patients with idiopathic aplastic anemia

      2013, Leukemia Research
      Citation Excerpt :

      In a large study of patients undergoing alloHSCT, the reported incidence of SOS was as high as 53% and the case fatality rate was 47% [1–3]. However, the reported incidence and fatality rates of SOS show high variability, ranging from 0% to 70% [4–6]. Recent reports indicate that the incidence and mortality are decreasing.

    • Management of hepatic vascular diseases

      2012, Journal of Hepatology

    • Pediatric Radiation Oncology

      2009, Oncology of Infancy and Childhood: Expert Consult - Online and Print

    • Time-related changes in the incidence, severity, and clinical outcome of hepatic veno-occlusive disease in hematopoietic stem cell transplantation patients during the past 10 years

      2005, Transplantation Proceedings
    View all citing articles on Scopus
    View full text
    Copyright © 1993 Published by Elsevier Ltd.